Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics.
暂无分享,去创建一个
Bin Xu | I. Ganly | R. Ghossein | R. Tuttle | Bin Xu | R Michael Tuttle | Mona M. Sabra | Ian Ganly | Ronald Ghossein | M. Sabra | Bin Xu | R. M. Tuttle
[1] Y. Min,et al. Prognostic Implications of Radioiodine Avidity and Serum Thyroglobulin in Differentiated Thyroid Carcinoma with Distant Metastasis , 2013, World Journal of Surgery.
[2] E. Bergstralh,et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. , 1992, Surgery.
[3] S. Piana,et al. Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis. , 2013, Human pathology.
[4] Bin Xu,et al. Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma , 2016, Endocrine Pathology.
[5] J. Shah,et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis , 2006, Cancer.
[6] R. Tsang,et al. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis , 2007, Cancer.
[7] T. Uruno,et al. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. , 2011, Thyroid : official journal of the American Thyroid Association.
[8] J. Mihailovič,et al. Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases , 2009, Nuclear medicine communications.
[9] E. Bergstralh,et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. , 1988, The Journal of clinical endocrinology and metabolism.
[10] David D. Smith,et al. The Implication of Lymph Node Metastasis on Survival in Patients with Well-Differentiated Thyroid Cancer , 2005, The American surgeon.
[11] Donavan T. Cheng,et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.
[12] L. Pomorski,et al. Metastasis as the first sign of thyroid cancer. , 1999, Neoplasma.
[13] J. Mihailovič,et al. Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors. , 2007, Cancer biotherapy & radiopharmaceuticals.
[14] R. Celestino,et al. TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas , 2014, The Journal of clinical endocrinology and metabolism.
[15] C. Hsieh,et al. Long‐term outcomes of distant metastasis from differentiated thyroid carcinoma , 2012, Clinical endocrinology.
[16] J. Ricarte-Filho,et al. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns , 2010, Modern Pathology.
[17] Jandee Lee,et al. Differentiated Thyroid Carcinoma Presenting With Distant Metastasis at Initial Diagnosis: Clinical Outcomes and Prognostic Factors , 2010, Annals of surgery.
[18] D. Yin,et al. Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta‐analysis , 2016, Clinical endocrinology.
[19] B. Lang,et al. Evaluating the Prognostic Factors Associated with Cancer-specific Survival of Differentiated Thyroid Carcinoma Presenting with Distant Metastasis , 2012, Annals of Surgical Oncology.
[20] M. Monden,et al. Fatal differentiated thyroid cancer , 1996, Journal of surgical oncology.
[21] C. Sander,et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. , 2016, The Journal of clinical investigation.
[22] Simion I. Chiosea,et al. Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules. , 2016, Endocrine-related cancer.
[23] S. Mane,et al. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. , 2015, Human molecular genetics.
[24] R. Ghossein. Encapsulated Malignant Follicular Cell-Derived Thyroid Tumors , 2010, Endocrine pathology.
[25] J. Shah,et al. Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. , 1996, American journal of surgery.
[26] R. DeLellis. Pathology and genetics of tumours of endocrine organs , 2004 .
[27] O. Ozaki,et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. , 1999, The Journal of clinical endocrinology and metabolism.
[28] I. Okayasu,et al. Papillary thyroid carcinoma with heterotopic ossification is a special subtype with extensive progression. , 2013, American journal of clinical pathology.
[29] I. Ganly,et al. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas. , 2016, Thyroid : official journal of the American Thyroid Association.